Collaboration - September 25, 2024
Ribo and Pheiron enter strategic collaboration for AI-assisted drug development
Ribocure Pharmaceuticals and Suzhou Ribo Life Science have entered a partnership with Pheiron to leverage its AI platform in Ribo’s discovery and development of RNA-based therapeutics.
Agreement - September 17, 2024
Navamedic enters agreement with Alex Therapeutics
Navamedic has partnered with Alex Therapeutics to aid in Parkinson’s treatment management.